PanGen Biotech Inc (222110) — Free Cash Flow Generation Index

Latest as of June 2025: 0.98x

PanGen Biotech Inc (222110) has a Free Cash Flow Generation Index of 0.98x as of June 2025. Free cash flow of ₩3.16 Billion represents 1% of operating cash flow (₩3.22 Billion). See PanGen Biotech Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.98x

Free Cash Flow / Operating CF

Free Cash Flow

₩3.16 Billion

KRW

Operating Cash Flow

₩3.22 Billion

KRW

Capital Expenditures

₩56.30 Million

KRW

PanGen Biotech Inc Free Cash Flow Generation Index (2024–2024)

Historical FCF Generation Index trend for PanGen Biotech Inc across 1 annual periods. Explore debt repayment capacity of PanGen Biotech Inc to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for PanGen Biotech Inc (2024–2024)

Year-by-year Free Cash Flow Generation Index for PanGen Biotech Inc. For the full company profile including market capitalisation, see market cap of PanGen Biotech Inc.

Year	FCG Index	Free Cash Flow (KRW)	Operating CF	Capital Expenditures	YoY Change
2024	0.87x	₩2.61 Billion	₩2.99 Billion	₩374.12 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).